Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Dennis

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|December 2, 2011
Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosusG J Dennis
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1986
Corticosteroid-induced suppression of murine B cell immune response antigensG J Dennis, J J Mond
Annals of Internal Medicine|November 15, 1991
Muscle infarction in sickle cell anemiaG J Dennis, R M Keating
Arthritis and Rheumatism|April 15, 2000
Clinical images: Diagnosis and treatment of retroperitoneal fibrosis (Ormond's disease)J M Poitras, G J Dennis
The Journal of Rheumatology|January 1, 1995
Focal myositisD R Finger, G J Dennis
Ergonomics|November 20, 2002
Spinal loads during individual and team liftingG J Dennis, R S Barrett
Arthritis and Rheumatism|August 1, 1993
Proteinuria associated with tolmetin treatment in a patient with systemic lupus erythematosusS A Vogelgesang, G J Dennis, F A Bauer
The Journal of Pediatrics|June 8, 2001
Juvenile dermatomyositis presenting with anasarca: A possible indicator of severe disease activityJ P Mitchell, G J Dennis, L G Rider
Autoimmunity|January 1, 1997
Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosusB Kovacs, S N Liossis, G J Dennis, et al.
The Journal of Clinical Investigation|April 29, 1998
Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chainS N Liossis, X Z Ding, G J Dennis, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|December 2, 2011
Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosusG J Dennis
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1986
Corticosteroid-induced suppression of murine B cell immune response antigensG J Dennis, J J Mond
Annals of Internal Medicine|November 15, 1991
Muscle infarction in sickle cell anemiaG J Dennis, R M Keating
Arthritis and Rheumatism|April 15, 2000
Clinical images: Diagnosis and treatment of retroperitoneal fibrosis (Ormond's disease)J M Poitras, G J Dennis
The Journal of Rheumatology|January 1, 1995
Focal myositisD R Finger, G J Dennis
Ergonomics|November 20, 2002
Spinal loads during individual and team liftingG J Dennis, R S Barrett
Arthritis and Rheumatism|August 1, 1993
Proteinuria associated with tolmetin treatment in a patient with systemic lupus erythematosusS A Vogelgesang, G J Dennis, F A Bauer
The Journal of Pediatrics|June 8, 2001
Juvenile dermatomyositis presenting with anasarca: A possible indicator of severe disease activityJ P Mitchell, G J Dennis, L G Rider
Autoimmunity|January 1, 1997
Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosusB Kovacs, S N Liossis, G J Dennis, et al.
The Journal of Clinical Investigation|April 29, 1998
Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chainS N Liossis, X Z Ding, G J Dennis, et al.
Pageof 3